Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development

[1]  E. Fontham,et al.  Interleukin-1β and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Gastric Cancer: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[2]  D. Raoult,et al.  The two faces of interleukin 10 in human infectious diseases. , 2006, The Lancet. Infectious diseases.

[3]  Christopher F. Martin,et al.  Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  A. Cox,et al.  Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review , 2006, BMC Cancer.

[5]  G. Pawelec,et al.  Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population , 2006, Cancer Immunology, Immunotherapy.

[6]  Jun Wang,et al.  EFFECTS OF HAPLOTYPES IN THE INTERLEUKIN 1&bgr; PROMOTER ON LIPOPOLYSACCHARIDE-INDUCED INTERLEUKIN 1&bgr; EXPRESSION , 2006, Shock.

[7]  Hongbing Shen,et al.  Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer. , 2006, Cancer letters.

[8]  Hongbing Shen,et al.  Functional variants in the promoter of interleukin‐1β are associated with an increased risk of breast cancer: A case‐control analysis in a Chinese population , 2006, International journal of cancer.

[9]  R. Hayes,et al.  Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. , 2006, Cancer research.

[10]  Wei Chen,et al.  Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer , 2006 .

[11]  J. Beebe-Dimmer,et al.  Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia , 2006, CA: a cancer journal for clinicians.

[12]  D. Noh,et al.  Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women , 2006, Breast Cancer Research and Treatment.

[13]  C. Cannings,et al.  Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. , 2006, Human molecular genetics.

[14]  R. R. Henry,et al.  Gastric cancer risk in a Mexican population: Role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin‐1 and ‐10 genes , 2006, International journal of cancer.

[15]  E. Fontham,et al.  Association of Interleukin-1β Gene Polymorphisms with Precancerous Gastric Lesions in African Americans and Caucasians , 2006, The American Journal of Gastroenterology.

[16]  G. Perez-Perez,et al.  Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica , 2005, Clinical and Experimental Medicine.

[17]  A. Strosberg,et al.  Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. , 2005, European cytokine network.

[18]  Astrid Dempfle,et al.  TNF-α, TNF-β, IL-6, and IL-10 Polymorphisms in Patients with Lung Cancer , 2005, Disease markers.

[19]  Joon-Yong Park,et al.  Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. , 2005, Cancer letters.

[20]  L. An,et al.  Association of interleukin-1B (IL-1B) gene polymorphisms with risk of gastric cancer in Chinese population. , 2005, Cytokine.

[21]  Kejun Liu,et al.  PowerMarker: an integrated analysis environment for genetic marker analysis , 2005, Bioinform..

[22]  H. Pandha,et al.  An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma. , 2005, The Journal of urology.

[23]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[24]  M. Blaser,et al.  Mechanisms of Disease: inflammation and the origins of cancer , 2005, Nature Clinical Practice Oncology.

[25]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[26]  R. Ness,et al.  Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. , 2004, American journal of epidemiology.

[27]  S. Witkin,et al.  Ethnic Differences of Polymorphisms in Cytokine and Innate Immune System Genes in Pregnant Women , 2004, Obstetrics and gynecology.

[28]  C. Prinz,et al.  Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection , 2004, Gut.

[29]  E. Fontham,et al.  Age at Acquisition of Helicobacter pylori Infection: Comparison of Two Areas with Contrasting Risk of Gastric Cancer , 2004, Helicobacter.

[30]  F. Breedveld,et al.  Correlation of polymorphic variation in the promoter region of the interleukin‐1β gene with secretion of interleukin‐1β protein , 2004 .

[31]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[32]  J. Sung,et al.  Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. , 2003, Gut.

[33]  C. Caldas,et al.  A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. , 2003, Gastroenterology.

[34]  C. Prinz,et al.  Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. , 2003, The Journal of infectious diseases.

[35]  Chien-Jen Chen,et al.  Interleukin‐10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese , 2003, International journal of cancer.

[36]  J. Goedert,et al.  Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. , 2003, Gastroenterology.

[37]  S. Lee,et al.  Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B -31 C/+ and IL-1RN *2/*2) and gastric cancer/duodenal ulcer in Korean population. , 2003, Cytokine.

[38]  Jianfeng Xu,et al.  Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. , 2003, Cytokine.

[39]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[40]  Leif E. Peterson,et al.  Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection , 2002 .

[41]  D. Harlan,et al.  Ethnicity Greatly Influences Cytokine Gene Polymorphism Distribution , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[42]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[43]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[44]  W. Ledger,et al.  Influence of interleukin-1 receptor antagonist gene polymorphism on disease. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  P. Pharoah,et al.  Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. , 2001, Gastroenterology.

[46]  M. Onda,et al.  Association of the interleukin-1 β genetic polymorphism and gastric cancer risk in Japanese , 2001, Journal of Gastroenterology.

[47]  K. Fearon,et al.  A polymorphism of the interleukin-1 β gene influences survival in pancreatic cancer , 2000, British Journal of Cancer.

[48]  F. Green,et al.  Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation* , 2000, The Journal of Biological Chemistry.

[49]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[50]  P. Woo,et al.  Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[51]  D. Hartl,et al.  Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. , 1998, Tissue antigens.

[52]  M. Hurme,et al.  IL‐1 receptor antagonist (IL‐1Ra) plasma levels are co‐ordinately regulated by both IL‐1Ra and IL‐1β genes , 1998 .

[53]  Santtila,et al.  Presence of the IL‐1RA Allele 2 (IL1RN*2) is Associated with Enhanced IL‐1β Production In Vitro , 1998, Scandinavian journal of immunology.

[54]  I. Beales,et al.  Interleukin 1β and tumour necrosis factor α inhibit acid secretion in cultured rabbit parietal cells by multiple pathways , 1998 .

[55]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[56]  M. Lazarus,et al.  An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[57]  P. Correa,et al.  The transmission of Helicobacter pylori. A critical review of the evidence. , 1995, International journal of epidemiology.

[58]  C. Dinarello,et al.  Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. , 1991, The Journal of biological chemistry.

[59]  D. Dripps,et al.  Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. , 1991, The Journal of biological chemistry.

[60]  M. Chou,et al.  Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. , 2006, Lung cancer.

[61]  C. Gabel,et al.  Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. , 2004, Arthritis and rheumatism.

[62]  R. Zeillinger,et al.  Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. , 2002, Journal of the Society for Gynecologic Investigation.

[63]  M. Hurme,et al.  IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. , 1998, European journal of immunology.

[64]  I. Udalova,et al.  -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. , 1995, Journal of inflammation.

[65]  B M Brinkman,et al.  Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. , 1995, Journal of inflammation.